Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Veralox Therapeutics, a US-based therapeutics developer exploiting technology from multiple academic research institutions, has raised $5.4m from seed investors including University of Maryland System’s Maryland Momentum Fund and University of Vermont’s Health Network. JRDF T1D Fund, managed by diabetes-focused charity JRDF, led the round with commitments from Virginia Tech Carilion (VTC) Innovation Fund and VTC Seed Fund – two VC partnerships between Virginia Tech and healthcare provider Carilion Clinic – as well as drug maker Sanofi’s Ventures unit and state-owned…
